The Mass Spectrometry & Proteomics (MSP) facility located within Clinical & Health Sciences at the University South Australia provides expertise for Tissue Mass Spectrometry Imaging and proteomic analyses. MSP is a Proteomics Node for Bioplatforms Australia in South Australia that was established under the National Collaborative Research Infrastructure Strategy (NCRIS).

We offer a wide range of analytical services for industry and academia such as protein identification, quantitative proteomics, phosphoproteomics and glycomics. In addition, we are experts in method development and have established mass spectrometry assays for specific analytes such as patulin in apple juice, bromoform in seaweed (a compound known to reduce methane production) and PFAS (the ‘forever chemicals’) in solid and fluid samples.

 

Engage with us


Request a quote

Contact us

Our People

Dr Manuela Klingler-Hoffmann
Biochemistry/Proteomics
Dr Clifford Young
Biochemistry/Proteomics/LC-MS/PTM Characterisation
Dr Matthew Briggs
MALDI Imaging/Glycomics
Dr Parul Mittal
MALDI Imaging/Cancer Proteomics
Dr Yevgeniya Grebneva
GC-MS/Environmental Science/Food Proteomics
Leigh Donnellan
LC-MS/Plant Proteomics

Pricing and Quotation

To receive a formal quote, please complete the MSP Quotation Request Form below. For more information or pricing guidelines, please download our MSP Facility Information Handbook

Client Details

Services required

*Please provide the protocol for sample preparation along with this form

Rate requested

Main Services

Quantitative Proteomics

Contact details

UniSA HB Building

Location Level 8, HB Building Cnr North Terrace and Morphett Street, Adelaide 5000

The University of South Australia Mass Spectrometry and Proteomics facility is supported by The University of South Australia, the State and Federal Governments and Bioplatforms Australia.

Funding Logos

Bioplatforms Australia’s Vision

Bioplatforms Australia enables Australian life science research by investing in state-of-the-art infrastructure and associated expertise in the specialist fields of genomics, proteomics, metabolomics and bioinformatics. Bioplatforms’ proteomics partners offer leading edge infrastructure, expertise and advanced protein discovery services. A broad range of services are offered including mass spectrometry, monoclonal antibody production and drug screening.

Bioplatforms Australia’s Mission

Bioplatforms Australia’s Mission is to support world class research and innovation in the life sciences by:

  • Ensuring broad and efficient access to state-of-the-art biomolecular (‘omic) platform capabilities.
  • Facilitating greater multi-disciplinary integration in basic and translational bioscience.
  • Contributing to research collaborations that address scientific challenges of national significance.
  • Supporting industrial applications of biomolecular technology and scientific collaborations between researchers and industry.
  • Expanding international research networks.
  • Sustaining a national intellectual capability and capacity.